FSI OFFER TO ACQUIRE AN AGRICULTURE COMPANY DECLINED

FSI OFFER TO ACQUIRE AN AGRICULTURE COMPANY DECLINED GlobeNewswire November 10, 2025 TABER, ALBERTA, Nov. 10, 2025 (GLOBE NEWSWIRE) — FLEXIBLE SOLUTIONS INTERNATIONAL, INC. (NYSE-AMERICAN: FSI), is the developer and manufacturer of biodegradable polymers for oil extraction, detergent ingredients and water treatment as well as crop nutrient availability chemistry. Flexible Solutions also manufactures biodegradable and […]

Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO(R) in Canada from Knight

Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO(R) in Canada from Knight GlobeNewswire November 10, 2025 TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets artificial intelligence (“AI”)-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased

Xtant Medical Reports Third Quarter 2025 Financial Results

Total Revenue of $33.3 Million Increased 19% Year-over-Year Delivers Positive Net Income, Adjusted EBITDA and Operating Cash Flow Reiterates FY25 Revenue Guidance of $131-$135 Million, Representing Growth of 11%-15% over FY24 Previously Announced Sale of Certain Hardware Assets and OUS Businesses to Companion Spine Anticipated to Close by Year-End Xtant Medical Holdings, Inc. (NYSE American:

Tandy Leather Factory Reports Third Quarter 2025 Results

(NASDAQ:TLF), FORT WORTH, Texas, Nov. 10, 2025 (GLOBE NEWSWIRE) — Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company's financial results for the third fiscal quarter of 2025. Highlights from third quarter 2025: Revenues were $17.3 million, down 0.5% from 2024 Generated operating loss of $0.7 million versus $0.3 million in 2024 Net loss

Crinetics Pharmaceuticals Announces November 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:CRNX), SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on November 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 37,675 shares of its common stock and granted an aggregate of 25,300 restricted stock unit (“RSU”)

Tandy Leather Factory Reports Third Quarter 2025 Results

Tandy Leather Factory Reports Third Quarter 2025 Results GlobeNewswire November 10, 2025 FORT WORTH, Texas, Nov. 10, 2025 (GLOBE NEWSWIRE) — Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company's financial results for the third fiscal quarter of 2025. Highlights from third quarter 2025: Revenues were $17.3 million, down 0.5% from 2024 Generated operating

Crinetics Pharmaceuticals Announces November 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces November 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire November 10, 2025 SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on November 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 37,675

Rollins, Inc. Announces Launch of Secondary Public Offering of Common Stock

Rollins, Inc. (NYSE: ROL) (“Rollins” or the “Company”) today announced the commencement of a proposed secondary public offering of $1.0 billion of shares of its common stock (the “Offering”) by LOR, Inc. and Rollins Holding Company, Inc., two of the Company's existing stockholders (together, the “Selling Stockholders”). The underwriter will have a 30-day option to

Red Robin Announces At-The-Market Equity Offering Program

Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) (the “Company”), a full-service restaurant chain serving an innovative selection of high-quality gourmet burgers in a family-friendly atmosphere, announced today the establishment of an “at-the-market equity offering” program (“ATM Program”), pursuant to which the Company may offer and sell shares of its common stock, with an aggregate gross

Lendway, Inc. Announces September 30, 2025 Financial Results

MINNEAPOLIS, MN / ACCESS Newswire / November 10, 2025 / Lendway, Inc. (Nasdaq:LDWY) ("Lendway" or the "Company") today announced its financial results for the three months ended September 30, 2025. Overview Three months ended September 30, 2025 Net revenue was $5.2 million. Gross loss was $0.06 million, or (1.2)% of sales. Operating loss of $3.0

Scroll to Top